- COVID Science Is Moving Backwards https://www.theatlantic.com/science/archive/2022/12/covid-science-data-bivalent-vaccines-paxlovid/672378/ 4 comments worldnews
Linking pages
Linked pages
- Global impact of the first year of COVID-19 vaccination: a mathematical modelling study - The Lancet Infectious Diseases https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00320-6/fulltext 830 comments
- CDC COVID Data Tracker https://covid.cdc.gov/covid-data-tracker/#trends_dailycases 531 comments
- Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection â Increasing Community Access to Testing Program, United States, SeptemberâNovember 2022 | MMWR https://www.cdc.gov/mmwr/volumes/71/wr/mm7148e1.htm?s_cid=mm7148e1_w 80 comments
- Effectiveness of Monovalent mRNA Vaccines Against COVID-19âAssociated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States â IVY Network, 18 States, December 26, 2021âAugust 31, 2022 | MMWR https://www.cdc.gov/mmwr/volumes/71/wr/mm7142a3.htm 52 comments
- Coronavirus (COVID-19) Vaccinations - Our World in Data https://ourworldindata.org/covid-vaccinations 34 comments
- A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2208343 33 comments
- Stay Up to Date with COVID-19 Vaccines | CDC https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html 27 comments
- Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2 | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2118946 18 comments
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://www.nejm.org/doi/full/10.1056/nejmoa2035389 18 comments
- Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2203965 15 comments
- https://www.science.org/doi/10.1126/science.abm3425 5 comments
- Medium COVID Could Be the Most Dangerous COVID - The Atlantic https://www.theatlantic.com/health/archive/2022/10/covid-symptoms-medium-term-post-infection-complications/671684/ 5 comments
- Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2116044 2 comments
- If You’ve Never Had COVID, Are You a Sitting Duck? - The Atlantic https://www.theatlantic.com/health/archive/2022/07/never-had-covid-infection-avoidance/670620/ 2 comments
- Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants | NEJM https://www.nejm.org/doi/full/10.1056/NEJMc2209479?query=featured_home 1 comment
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2034577 1 comment
- Covid-19 Vaccine Tracker: Latest Updates - The New York Times https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html 0 comments
- The lightning-fast quest for COVID vaccines — and what it means for other diseases https://www.nature.com/articles/d41586-020-03626-1 0 comments
- The Pfizer, Moderna, and Johnson & Johnson Vaccines, Compared - The Atlantic https://www.theatlantic.com/health/archive/2021/03/pfizer-moderna-and-johnson-johnson-vaccines-compared/618226/ 0 comments
- Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2116846 0 comments
Related searches:
Search whole site: site:www.theatlantic.com
Search title: COVID Science Is Moving Backwards - The Atlantic
See how to search.